- Assistant Professor, Global Health
- Assistant Professor, Medicine - Allergy and Infectious Dis.
Select from the following:
Dr. LaCourse’s research focuses on improving TB screening and prevention in HIV-infected peripartum women and their children and has multiple ongoing research projects primarily in Kenya.
Dr. LaCourse is a GWACh (Global Women, Adolescent, and Child health) scientific lead, Kenya Research and Training Center (KRTC) faculty member, Tuberculosis Research & Training Center (TRTC) leadership committee member, and TB ECHO (Extension for Community Healthcare Outcomes) faculty. She is committed to the inclusion of children and pregnant women in HIV/TB research as an IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials Network) TB Scientific Committee mentored junior investigator, and International Union Against TB and Lung Disease Maternal Child Health Working Group Scientific Co-Lead.
She is an attending physician at the Madison HIV clinic and infectious diseases, general medicine, and HIV inpatient services at the University of Washington and Harborview Medical Centers.
- Child and Adolescent Health (incl. Pediatrics)
- Infectious Diseases
- Maternal Child Health (incl. Reproductive Health)
- COVID-19 prevalence, household transmission, and antibody response among pregnant women and adult household their pediatric and members in South King County, WA state
- Dynamics of tuberculosis immune response in peripartum HIV-infected and HIV-uninfected women
- Impact of maternal HIV on Mycobacterium tuberculosis (Mtb) infection among peripartum women and their infants.
- Kenya Tuberculosis Research & Training Program-UW (KTRTP UW)
- NanoDisk-MS measured Mtb antigen peptides for TB diagnosis and treatment monitoring in HIV-infected children
- The effect of HIV exposure and infection on immunity to TB in children
LaCourse SM, Kachikis A, Blain M, Simmons LE, Mays JA, et. al. Low prevalence of SARS-CoV-2 among pregnant and postpartum patients with universal screening in Seattle, Washington Clin Infect Dis. 2020 May 30. 10.1093/cid/ciaa675 30 May 2020 PMCID: PMC7314151
LaCourse SM, Richardson BA, Kinuthia J, Warr AJ, Maleche-Obimbo E, Matemo D, Cranmer LM, Mecha J,Escudero JN, Hawn TR, John-Stewart GC. A randomized controlled trial of isoniazid to prevent Mycobacterium tuberculosis infection in Kenyan HIV-exposed uninfected infants. Clin Infect Dis. [published online ahead of print, 2020 Jun 21]. Clin Infect Dis. 2020;ciaa827. doi:10.1093/cid/ciaa827
LaCourse SM, John-Stewart G, Adams Waldorf KM. Importance of inclusion of pregnant and breastfeeding women in COVID-19 therapeutic trials. Clin Infect Dis. 2020 Apr 15. pii: ciaa444. doi: 10.1093/cid/ciaa444
LaCourse SM, Cranmer LM, Njuguna IN, Gatimu J, Maleche-Obimbo E, Walson JL, Wamalwa D, John-Stewart GC, Pavlinac PB. Urine TB LAM positivity predicts mortality in HIV-infected hospitalized children. Clin Infect Dis. 2018 May 17; 66(11): 1798–1801 PMCID: 5961239
LaCourse SM, Pavlinac PB#, Cranmer LM , Njuguna IN, Mugo C, Gatimu J, Stern J, Walson JI , Maleche-Obimbo E, Oyugi J, Wamalwa D, John-Stewart GC. Stool Xpert MTB/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children. AIDS. 2018 Jan 2;32(1):69-78. PMCID: 5812271.